STXBP1

STXBP1

Overview

```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
STXBP1["STXBP1"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
STXBP1["STXBP1"] -.->|"inhibits"| SYNGAP1["SYNGAP1"]
STXBP1["STXBP1"] -.->|"inhibits"| ERK["ERK"]
STXBP1["STXBP1"] -->|"therapeutic_target"| Aging["Aging"]
STXBP1["STXBP1"] -->|"therapeutic_target"| Als["Als"]
STXBP1["STXBP1"] -->|"therapeutic_target"| Ms["Ms"]
STXBP1["STXBP1"] -->|"therapeutic_target"| Epigenetic["Epigenetic"]
STXBP1["STXBP1"] -->|"therapeutic_target"| SCN1A["SCN1A"]
STXBP1["STXBP1"] -.->|"inhibits"| Chaperone["Chaperone"]
STXBP1["STXBP1"] -->|"interacts_with"| AND["AND"]
STXBP1["STXBP1"] -->|"interacts_with"| DNAJC5["DNAJC5"]
STXBP1["STXBP1"] -->|"interacts_with"| Neurodegeneration["Neurodegeneration"]
STXBP1["STXBP1"] -->|"interacts_with"| ALS["ALS"]
STXBP1["STXBP1"] -->|"interacts_with"| Synaptic_Vesicle["Synaptic Vesicle"]
STXBP1["STXBP1"] -->|"expressed_in"| Neuron["Neuron"]
STXBP1["STXBP1"] -->|"interacts_with"| SNAP_25["SNAP-25"]
STXBP1["STXBP1"] -->|"interacts_with"| HSC70["HSC70"]
STXBP1["STXBP1"] -->|"interacts_with"| MUNC18_1["MUNC18-1"]
STXBP1["STXBP1"] -->|"interacts_with"| Proteins["Proteins"]
STXBP1["STXBP1"] -->|"associated_with"| ALS["ALS"]
STXB

STXBP1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">STXBP1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>STXBP1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q34.11</td>
</tr>
<tr>
<td class="label">Genomic Coordinates</td>
<td>chr9:127,750,000-127,870,000 (GRCh38)</td>
</tr>
<tr>
<td class="label">Gene Length</td>
<td>~120 kb</td>
</tr>
<tr>
<td class="label">Number of Exons</td>
<td>20 coding exons</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>~2.4 kb coding sequence</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>594 amino acids</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>SM (Sec1/Munc18-like) protein; synaptic vesicle fusion regulator</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (neurons throughout); lower expression in other tissues</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602926</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P61764</td>
</tr>
<tr>
<td class="label">Disorder</td>
<td>Variant Type</td>
</tr>
<tr>
<td class="label">STXBP1 encephalopathy (with epilepsy)</td>
<td>Missense, nonsense, truncating, splice</td>
</tr>
<tr>
<td class="label">Non-syndromic intellectual disability</td>
<td>Missense, truncating</td>
</tr>
<tr>
<td class="label">Autism spectrum disorder</td>
<td>Missense, variants</td>
</tr>
<tr>
<td class="label">Schizophrenia</td>
<td>Missense, variants</td>
</tr>
</table>

[STXBP1](/entities/stxbp1) encodes Munc18-1 (also known as STXBP1), a critical regulator of synaptic vesicle exocytosis. Pathogenic variants in [STXBP1](/entities/stxbp1) cause STXBP1 encephalopathy, one of the most common genetic causes of early-onset developmental and epileptic encephalopathies (DEEs). The disorder presents with neonatal seizures, a distinctive burst suppression EEG pattern, and profound developmental impairment.

[STXBP1](/entities/stxbp1) is notable for being one of the most intolerant genes in the human genome (pLI = 1.0), reflecting the severe fitness consequence of loss-of-function variants. It is also associated with non-epileptic neurodevelopmental disorders (intellectual disability, autism, schizophrenia) in patients without seizures["@stxbp1gene2023"].

Gene Information

Structure and Function

Munc18-1 Protein Structure

Munc18-1 is a member of the Sec1/Munc18 (SM) protein family, which are essential for intracellular membrane fusion events. The structure consists of:

• Arch-fold domain: characteristic of SM proteins, formed by three lobes (domains 1-3)
• Syntaxin-1 binding groove: deep cleft where syntaxin-1 binds in a closed conformation
• Phosphorylation sites: regulated by kinases including PKC and CaMKII

Role in Synaptic Vesicle Fusion

Munc18-1 is a master organizer of the synaptic vesicle fusion machinery:

1. Synaptic Vesicle Priming

• Munc18-1 binds syntaxin-1, stabilizing it in a closed conformation
• This enables assembly of the SNARE complex (synaptobrevin/VAMP2 on the vesicle, SNAP-25 on the plasma membrane, syntaxin-1 on the plasma membrane)
• Munc18-1 catalyzes the transition of vesicles from a pool to a fusion-competent "primed" state

2. SNARE Complex Assembly

• Munc18-1 acts as a chaperone for syntaxin-1 folding and trafficking
• It holds syntaxin-1 in the proper conformation for SNARE complex formation
• Without Munc18-1, syntaxin-1 fails to properly incorporate into SNARE complexes

3. Calcium Sensing Coordination

• Munc18-1 interacts with synaptotagmin-1 (the calcium sensor for vesicle fusion)
• It couples the calcium signal to the fusion machinery
• Munc18-1 may help position vesicles for optimal calcium-triggered fusion

4. Regulation by Phosphorylation

• PKC phosphorylation of Munc18-1 modulates its interactions
• CaMKII phosphorylation affects vesicle release probability
• Activity-dependent regulation of Munc18-1 contributes to synaptic plasticity

Cellular and Network Consequences

Loss of Munc18-1 disrupts both inhibitory (GABAergic) and excitatory (glutamatergic) transmission:

• Reduced vesicle priming → fewer fusion-ready vesicles
• Impaired SNARE complex function → inefficient fusion events
• Disrupted calcium coupling → desynchronized release
• Network hyperexcitability → seizures
• Impaired plasticity → developmental dysfunction

Disease Associations

Genotype-Phenotype Correlations

• Missense variants in domain 1 (S1-S3): often severe
• Truncating variants: severe; NMD and haploinsufficiency
• Splice variants: variable, often severe
• Mosaic variants (parental): milder phenotype possible

Therapeutic Approaches

Gene Therapy

STXBP1 is a high-priority gene therapy target:

• Haploinsufficiency mechanism (50% expression likely beneficial)
• Gene size (~2kb coding) easily fits in AAV
• Early intervention before developmental regression critical

Key Challenges

Research and Open Questions

References

Pathway Diagram

The following diagram shows the key molecular relationships involving STXBP1 discovered through SciDEX knowledge graph analysis: